Mutations in CRBN and other cereblon pathway genes are infrequently associated with acquired resistance to immunomodulatory drugs.
View/ Open
Date
2021-10-01Author
Jones, JR
Barber, A
Le Bihan, Y-V
Weinhold, N
Ashby, C
Walker, BA
Wardell, CP
Wang, H
Kaiser, MF
Jackson, GH
Davies, FE
Chopra, R
Morgan, GJ
Pawlyn, C
Type
Journal Article
Metadata
Show full item recordCollections
Research team
Myeloma Biology and Therapeutics
Target Evaluation and Molecular Therapeutics
Hit Discovery & Structural Design
Language
eng
Date accepted
2021-07-27
Citation
Leukemia, 2021, 35 (10), pp. 3017 - 3020
Publisher
SPRINGERNATURE